TREM2 and Alzheimer disease: sTREM2 in CSF is a surrogate measure of TREM2-triggered microglial activity, and recent studies noted that it increased in early symptomatic stages of patients with AD and aging adults (Henjum et al., 2016; Suárez-Calvet et al., 2016).